SCHEDULE: FMR LLC Discloses 5.7% Stake in HeartFlow Inc
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have reported a 5.7% beneficial ownership stake in HeartFlow Inc's common stock as of September 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson jointly filed a Schedule 13G, indicating beneficial ownership in HeartFlow Inc.
- They collectively beneficially own 4,730,234.08 shares of HeartFlow Inc.'s common stock.
- This ownership represents 5.7% of the total outstanding common stock of HeartFlow Inc.
- The shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of HeartFlow Inc.
- FMR LLC is identified as a parent holding company, and Abigail P. Johnson serves as its Director, Chairman, and Chief Executive Officer, and is part of the controlling Johnson family group.
Sentiment
Score: 7
Explanation: The filing indicates a significant passive investment by a major institutional investor, FMR LLC, which is generally viewed positively as a vote of confidence in the company. No negative information is presented within this ownership disclosure.
Positives
- A significant passive stake (5.7%) by a major institutional investor, FMR LLC (Fidelity), signals potential confidence in HeartFlow Inc.'s long-term prospects.
- The investment is stated to be in the ordinary course of business, indicating a passive investment rather than an activist stance that might imply dissatisfaction with current management or strategy.
Future Outlook
This Schedule 13G filing is an ownership disclosure and does not contain forward-looking statements or guidance from HeartFlow Inc. It solely reflects FMR LLC's passive investment position.
Industry Context
The disclosure of a significant stake by a major asset manager like FMR LLC in HeartFlow Inc. could be interpreted as a positive indicator for the medical technology or healthcare diagnostics sector, particularly for companies specializing in non-invasive cardiovascular assessment.
Comparison to Industry Standards
- This filing is an ownership disclosure and does not provide operational or financial results for comparison to industry standards or specific comparable companies.
Stakeholder Impact
- Shareholders: Increased institutional ownership may provide stability and confidence in the company's stock.
- Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this passive ownership filing, as it does not pertain to HeartFlow Inc.'s operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2025-09-30 | Date of event requiring the filing of this statement, as reported in the filing. |
| 2025-11-04 | Date of filing of this Schedule 13G by FMR LLC and Abigail P. Johnson. |
Recommendation
holdThis Schedule 13G filing confirms a significant passive stake by FMR LLC, a prominent institutional investor. While this is generally a positive signal of investor confidence, the filing itself does not offer new operational or financial data about HeartFlow Inc. that would justify a 'buy' or 'sell' recommendation. Investors should 'hold' their position and await further company-specific news or financial reports for a more comprehensive investment decision.
Keywords
HeartFlow Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Common Stock, Institutional Ownership, Fidelity, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.